Blogpost

Key Takeaways from the World Orphan Drug Congress

The World Orphan Drug Congress brought us together with the top stakeholders in rare and orphan disease. Here are our top three takeaways. Artificial Intelligence is here to stay. … Read More

Featured Post

Therapy Onboarding Optimization: Why the Analytics of Patient Dropoff Requires a Closer Look

From April 2020 to August 2021, the healthcare solutions company Indegene looked at approximately 7.9 million emails sent by prescription drug companies across 15 different email campaigns. The results, reported in April 2022 by Fierce Pharma, highlighted the need for brands to more carefully manage how they engage with healthcare providers in a post-COVID world … Read More

Featured Post

Three Pitfalls to Avoid When Planning Digital Customer Onboarding

As a business leader, it might be tempting to delegate all things digital to your IT department. This is especially true among small businesses, for whom the IT “department” might consist of a single person. … Read More

Featured Post

Why Script to Dispense Conversion will take Centre Stage in 2023

With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors. The pharmaceutical industry is no exception. … Read More

Featured Post

The Patient Journey Tech Stack: 10 Predictions for 2023

As a result, manufacturers are finally taking ownership of their patient journey technology stack. Their willingness to absorb painful system integration cycles have brought many to the conclusion that patient support services technologies should not and cannot be relegated to one-off patient-support vendors. … Read More

Featured Post

Industry leaders offer reflections on 2022 and predictions for 2023

Our founder, Yishai Knobel was featured by MM+M regarding his thoughts on the top trends in 2023. To quote his comments from the larger article: “In 2023, forced to navigate trickier patient journeys and constrained marketing budgets, specialty patient services will be forced to rethink how to reach the 80% patients who never reach the Hub,” said RxWare CEO Yishai Knobel. … Read More

Featured Post

The Gateway to Specialty Patient Journey

This week’s episode, produced by the Digital Health Community here at Persimmon Health, features Yishai Knobel. Yishai is the Co-founder and Chief Executive Officer of RxWare (Formerly HelpAround), a patient journey solution startup that offers pharma manufacturers a “vendor-neutral digital infrastructure” to optimize and accelerate the complete patient journey. … Read More

Featured Post

Bethesda startup rebrands amid growing demand to help patients stick with prescriptions

Our CEO, Yishai Knobel was recently interviewed by Sara Gilgore, a staff writer for the Washington Business Journal about the evolution of RxWare, the name change from HelpAround, and where he sees the future of the company and its mission to make it easier for patients to access and adhere to medication. … Read More

Featured Post

HelpAround is now RxWare!

We are excited to announce that starting today HelpAround is RxWare.

When we began our journey years ago, it was as a company on a mission to simplify patients’ lives, initially by providing a support network for type-1 diabetes families. While our mission has not changed, we pursue it today by enabling specialty drug manufacturers to do the same by simplifying therapy onboarding for patients. … Read More

Featured Post

Specialty pharma’s next big opportunity: it’s time for Patient Access to adopt an open protocol

An inflection point now faces the specialty pharmaceutical industry. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. Not unlike the financial industry, these institutions still exchange patient information via fax machines. … Read More

Featured Post